111 related articles for article (PubMed ID: 26407335)
1. Effects of polyvalent immunoglobulins in patients with recurrent pregnancy loss and antibodies to the choriocarcinoma cell line JEG-3.
Rogenhofer N; von Schönfeldt V; Ochsenkühn R; Sili F; Thaler CJ
Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():161-7. PubMed ID: 26407335
[TBL] [Abstract][Full Text] [Related]
2. Antitrophoblast antibodies are associated with recurrent miscarriages.
Rogenhofer N; Ochsenkühn R; von Schönfeldt V; Assef RB; Thaler CJ
Fertil Steril; 2012 Feb; 97(2):361-6. PubMed ID: 22154370
[TBL] [Abstract][Full Text] [Related]
3. Sera of patients with recurrent miscarriages containing anti-trophoblast antibodies (ATAB) reduce hCG and progesterone production in trophoblast cells in vitro.
von Schönfeldt V; Rogenhofer N; Ruf K; Thaler CJ; Jeschke U
J Reprod Immunol; 2016 Sep; 117():52-6. PubMed ID: 27472296
[TBL] [Abstract][Full Text] [Related]
4. Effects of intralipid infusions on anti-trophoblast antibody (ATAb)-activities in patients with recurrent pregnancy loss: An observational report.
Rogenhofer N; Mahner S; von Hasselbach YL; Thaler CJ
Am J Reprod Immunol; 2022 Feb; 87(2):e13506. PubMed ID: 34935238
[TBL] [Abstract][Full Text] [Related]
5. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
Sapir T; Carp H; Shoenfeld Y
Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
[TBL] [Abstract][Full Text] [Related]
6. Idiotypic and anti-idiotypic elastin autoantibodies: Implications for IVIg and pregnancy loss.
Konova E; Atanasova M; Stoykov S; Velkova A; Shoenfeld Y
J Autoimmun; 2007 Feb; 28(1):46-54. PubMed ID: 17178213
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
[TBL] [Abstract][Full Text] [Related]
8. Effects of anti-β2-glycoprotein I antibody on PlGF, VEGF and sVEGFR1 production from cultured choriocarcinoma cell line.
Ichikawa G; Yamamoto T; Chishima F; Nakamura A; Kuno S; Murase T; Suzuki M
J Obstet Gynaecol Res; 2011 Aug; 37(8):1076-83. PubMed ID: 21501325
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3(+) regulatory T cells in pregnant women with recurrent pregnancy loss.
Kim DJ; Lee SK; Kim JY; Na BJ; Hur SE; Lee M; Kwak-Kim J
Am J Reprod Immunol; 2014 May; 71(5):441-50. PubMed ID: 24645850
[TBL] [Abstract][Full Text] [Related]
10. Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL).
Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Afkham A; Danaii S; Abdollahi-Fard S; Heidari L; Jadidi-Niaragh F; Younesi V; Nouri M; Yousefi M
Biomed Pharmacother; 2017 Aug; 92():1095-1102. PubMed ID: 28622710
[TBL] [Abstract][Full Text] [Related]
11. Preimplantation factor inhibits circulating natural killer cell cytotoxicity and reduces CD69 expression: implications for recurrent pregnancy loss therapy.
Roussev RG; Dons'koi BV; Stamatkin C; Ramu S; Chernyshov VP; Coulam CB; Barnea ER
Reprod Biomed Online; 2013 Jan; 26(1):79-87. PubMed ID: 23186554
[TBL] [Abstract][Full Text] [Related]
12. The haplotype M2 of the ANXA5 gene is not associated with antitrophoblast antibodies.
Rogenhofer N; Engels L; Bogdanova N; Tüttelmann F; Markoff A; Thaler CJ
J Assist Reprod Genet; 2013 Jun; 30(5):711-6. PubMed ID: 23529182
[TBL] [Abstract][Full Text] [Related]
13. Effect of IgG therapy on lymphocyte subpopulations in the peripheral blood of Kuwaiti women experiencing recurrent pregnancy loss.
Mahmoud F; Diejomaoh M; Omu A; Abul H; Haines D
Gynecol Obstet Invest; 2004; 58(2):77-83. PubMed ID: 15114031
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
Sapir T; Blank M; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
[TBL] [Abstract][Full Text] [Related]
15. Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?
Yang X; Meng T
J Immunol Res; 2020; 2020():6672865. PubMed ID: 33426092
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-11 increases invasiveness of JEG-3 choriocarcinoma cells by modulating STAT3 expression.
Suman P; Poehlmann TG; Prakash GJ; Markert UR; Gupta SK
J Reprod Immunol; 2009 Oct; 82(1):1-11. PubMed ID: 19716605
[TBL] [Abstract][Full Text] [Related]
17. Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities.
Lee SK; Kim JY; Han AR; Hur SE; Kim CJ; Kim TH; Cho BR; Han JW; Han SG; Na BJ; Kwak-Kim J
Am J Reprod Immunol; 2016 Jan; 75(1):59-68. PubMed ID: 26510488
[TBL] [Abstract][Full Text] [Related]
18. Increased Anti-HSP60 and Anti-HSP70 Antibodies in Women with Unexplained Recurrent Pregnancy Loss.
Matsuda M; Sasaki A; Shimizu K; Kamada Y; Noguchi S; Hiramatsu Y; Nakatsuka M
Acta Med Okayama; 2017 Jun; 71(3):201-208. PubMed ID: 28655939
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss.
Bu C; Zhang C; Li Z; Gao L; Xie Z; Cai G
Clin Exp Immunol; 2007 Jul; 149(1):31-9. PubMed ID: 17425656
[TBL] [Abstract][Full Text] [Related]
20. Enzyme linked immunosorbent assay (ELISA) as screening method for anti-paternal allo-antibodies in patients with recurrent pregnancy loss (RPL).
Rogenhofer N; Toth B; Kiessig S; Hellstern P; Taborski U; Scholz S; Thaler CJ
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):155-9. PubMed ID: 17459562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
